Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

Clinical trial NCT03560362 · UNKNOWN

Trial details

NCT number: NCT03560362
Sponsor: University of Tennessee
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pain, Postoperative Lung Cancer

Start date: 2015-07-09
Primary completion: 2018-10-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.